MedTrace Logo

Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication

NCT04798625 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2300

Last updated 2024-02-23

No results posted yet for this study

Summary

The purpose of this study is to assess the strength and duration of the immunological response to COVID-19 vaccines in patients treated with immunosuppressive and/or immunomodulating medication for immune-mediated inflammatory diseases in rheumatology and gastroenterology and after a liver transplantation.

Conditions

Sponsors & Collaborators

  • University Hospital, Akershus

    collaborator OTHER

  • Diakonhjemmet Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-15
Primary Completion
2026-02-15
Completion
2027-02-15

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04798625 on ClinicalTrials.gov